Evidence map›Paper›PMID 21658262›Full record

Trial reportTrials2011

The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial.

Lawrence Mbuagbaw, Lehana Thabane, Pierre Ongolo-Zogo, Trudie Lang

Registry-linked trialAbstract readEditorialRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03394456 (Technology to Improve the Health of Resource-poor Hispanics With Diabetes), which is not on this map. Cited by 38 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03394456 nacompletednot on this mapstarted 2018, after this paper: background citation

Technology to Improve the Health of Resource-poor Hispanics With Diabetes

TypeinterventionalSponsorBaylor College of MedicineRan2018 to 2022Enrolled265ConditionsDiabetes Mellitus, Type 2Armsdiabetes program, telehealth training and support for Community Health Workers
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Towards equitable AI in oncology.Nature reviews. Clinical oncology · 2024
    Review
  12. Randomised clinical trials in surgery: are we at a crossroads?Annals of medicine and surgery (2012) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lawrence MbuagbawCentre for the Development of Best Practices in Health (CDBPH), Yaoundé Central Hospital, Yaoundé, Cameroon. mbuagbawl@yahoo.com
Lehana Thabane
Pierre Ongolo-Zogo
Trudie Lang

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Conducting clinical trials in developing countries often presents significant ethical, organisational, cultural and infrastructural challenges to researchers, pharmaceutical companies, sponsors and regulatory bodies. Globally, these regions are under-represented in research, yet this population stands to gain more from research in these settings as the burdens on health are greater than those in developed resourceful countries. However, developing countries also offer an attractive setting for clinical trials because they often have larger treatment naive populations with higher incidence rates of disease and more advanced stages. These factors can present a reduction in costs and time required to recruit patients. So, balance needs to be found where research can be encouraged and supported in order to bring maximum public health benefits to these communities. The difficulties with such trials arise from problems with obtaining valid informed consent, ethical compensation mechanisms for extremely poor populations, poor health infrastructure and considerable socio-economic and cultural divides. Ethical concerns with trials in developing countries have received attention, even though many other non-ethical issues may arise. Local investigator initiated trials also face a variety of difficulties that have not been adequately reported in literature. This paper uses the example of the Cameroon Mobile Phone SMS trial to describe in detail, the specific difficulties encountered in an investigator-initiated trial in a developing country. It highlights administrative, ethical, financial and staff related issues, proposes solutions and gives a list of additional documentation to ease the organisational process.

Indexed as

Cell PhoneDeveloping CountriesHealth ResourcesMedication AdherencePatient SelectionResearch Support as TopicAnti-Retroviral AgentsAttitude of Health PersonnelCameroonClinical CompetenceCommunication BarriersCompensation and RedressCultural CharacteristicsHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansAnti-Retroviral Agents

Identifiers

PMID21658262
PMCPMC3138444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.